PainReform Ltd (PRFX) Down 1.75% in Premarket Trading

PainReform Ltd (PRFX) is down Monday morning, with the stock decreasing -1.75% in pre-market trading to 6.72. PRFX's short-term technical score of 36 indicates that the stock has traded less bullishly over the last month than 64% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 131 out of 146 industries, PainReform Ltd ranks higher than 57% of stocks. PainReform Ltd has risen 24.59% over the past month, closing at $6.44 on July 3. During this period of time, the stock fell as low as $4.05 and as high as $26.41. PRFX has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.

PRFX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on PRFX!

See Full PRFX Report

PainReform Ltd has a Long-Term Technical rank of 75. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 25% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 138 by this metric, PRFX ranks better than 138% of stocks.

Important Dates for Investors in PRFX:

-PainReform Ltd is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $-0.82. -We do not have a set dividend date for PainReform Ltd at this time. Click Here To Get The Full Report on PainReform Ltd (PRFX)